Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-7,785
Closed -$428K – 438
2020
Q1
$428K Sell
7,785
-122
-2% -$8.18K 0.09% 193
2019
Q4
$571K Sell
7,907
-220
-3% -$15K 0.09% 206
2019
Q3
$537K Buy
8,127
+2,374
+41% +$153K 0.09% 205
2019
Q2
$357K Buy
5,753
+441
+8% +$25.5K 0.06% 249
2019
Q1
$288K Buy
+5,312
New +$299K 0.05% 291
2016
Q3
– Sell
-4,217
Closed -$243K – 370
2016
Q2
$243K Sell
4,217
-90
-2% -$5.16K 0.02% 545
2016
Q1
$260K Sell
4,307
-146
-3% -$8.18K 0.02% 510
2015
Q4
$243K Sell
4,453
-83
-2% -$4.76K 0.02% 531
2015
Q3
$258K Buy
+4,536
New +$260K 0.02% 563

Other funds holding DOX

Arden Trust's DOX Position: Q2 2020 in Review

Arden Trust sold out of Amdocs (DOX) in Q2 2020, closing a stake of 7,785 shares — an estimated $428K sold.

Arden Trust first reported a position in DOX in Q3 2015 and held it in 9 quarters. The position peaked at $571K in Q4 2019. 408 funds tracked by Wall St. Rank hold DOX as of Q2 2020.

  • Arden Trust reported no remaining Amdocs position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 7,785 Amdocs shares in Q2 2020, an estimated $428K.
  • Arden Trust first reported a position in Amdocs in Q3 2015 and held it in 9 quarters.
  • Arden Trust's Amdocs position peaked at $571K in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Amdocs as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.